Birdwatch Note Rating
2024-05-06 21:58:12 UTC - HELPFUL
Rated by Participant: D8932C7808FAEE90093E6C9A89F9A00DA3089CF1162B5E29E79A66B83AEA10BF
Participant Details
Original Note:
The revocation was made at the request of AstraZeneca itself: ".... withdrawing, at the holder's request, the marketing authorisation granted by Decision C(2021) 698(final) for "Vaxzevria - COVID-19 Vaccine (ChAdOx1-S [recombinant])", a medicinal product for human use" https://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_en.pdf
All Note Details